Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06918561 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluating the Efficacy of NeoThelium FT in the Treatment of Chronic Open Wounds

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 17, 2026 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Site details revised at 3 of 14 sitesv11
  2. Trial sites expanded: 3 → 14 locationsv10
  3. Site details revised at 2 of 3 sitesv9
  4. Study sites: 2 to 3v8
  5. Re-verified, no change to tracked fieldsv7
Show 5 earlier versionsHide 5 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 2
    • Start date changed from estimate of Oct 1, 2025 to Oct 16, 2025
    v6
  2. Start date: Aug 1, 2025 to Oct 1, 2025v5
  3. Re-verified, no change to tracked fieldsv4
  4. Start date: Jul 1, 2025 to Aug 1, 2025v3 Show 5 more changesShow less
    • Primary completion date: Jul 1, 2026 to Aug 1, 2026
    • Study completion date: Sep 1, 2026 to Oct 1, 2026
    • Eligibility criteria expanded, about 36 words
    • Secondary endpoints: 5 to 2
    • Study description expanded, about 69 words
  5. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a randomized controlled crossover trial evaluating the efficacy of NeoThelium FT in conjunction with standard of care vs. standard of care alone in treating chronic open wounds.
Trial Details
NCT Number NCT06918561
Lead Sponsor NuScience Medical Biologics, LLC
Collaborators: SygNola, LLC
Conditions
(from sponsor)		 Open Wound
Enrollment 132 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov